Oriel Therapeutics Inc is categorized under Wholesale Pharmaceutical Products in Durham, NC and active since 2010.
Oriel Therapeutics Inc was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Richard Fuller at the company’s single location by writing to 630 Davis Drive # 120, Durham, North Carolina NC 27713 or by phoning (919) 313-1290. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Oriel Therapeutics Inc |
Contact Person: | Richard Fuller |
Address: | 630 Davis Drive # 120, Durham, North Carolina 27713 |
Phone Number: | (919) 313-1290 |
Website Address: | us.sandoz.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Oriel Therapeutics Inc was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Richard Fuller for inquiries that concern Oriel Therapeutics Inc by calling the company number (919) 313-1290, as your correspondence is most welcome. Additionally, the physical location of the single location of Oriel Therapeutics Inc can be found at the coordinates 35.873215,-78.862948 as well as the street address 630 Davis Drive # 120 in Durham, North Carolina 27713.
For its online presence, you may visit Oriel Therapeutics Inc’s website at us.sandoz.com and engage with its social media outlets through on Twitter and on Facebook.